The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Pleiotropic Effects of Statins - Basic Research and Clinical Perspectives -
Open accessAbstract
Statins are 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, which are widely used to lower serum cholesterol levels in the primary and secondary prevention of cardiovascular disease. Recent experimental and clinical evidence suggests that the beneficial effects of statins may extend beyond their cholesterol-lowering effects, to include so-called pleiotropic effects. These cholesterol-independent effects include improving endothelial function, attenuating vascular and myocardial remodeling, inhibiting vascular inflammation and oxidation, and stabilizing atherosclerotic plaques. The mechanism underlying some of these pleiotropic effects is the inhibition of isoprenoid synthesis by statins, which leads to the inhibition of intracellular signaling molecules Rho, Rac and Cdc42. In particular, inhibition of Rho and one of its downstream targets, Rho kinase, may be a predominant mechanism contributing to the pleiotropic effects of statins. The aim of the present review is to provide an update on the non-cholesterol-dependent statin effects in the cardiovascular system and highlight some of the recent findings from bench to bedside to support the concept of statin pleiotropy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
Inflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,736
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., & Zeiher, A. M. (1999) · Nature · doi:10.1038/21224 · Cited by 3,591
Rho GTPases and signaling networks
Van Aelst, L., & D’Souza-Schorey, C. (1997) · Genes & Development · doi:10.1101/gad.11.18.2295 · Cited by 2,358
Hypertension in mice lacking the gene for endothelial nitric oxide synthase
Huang, P. L., Huang, Z., Mashimo, H., Bloch, K. D., Moskowitz, M. A., Bevan, J. A., & Fishman, M. C. (1995) · Nature · doi:10.1038/377239a0 · Cited by 2,070
Molecular Bases of the Acute Coronary Syndromes
Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,028
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
Laufs, U., La Fata, V., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,839
Self-citationDe Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
Self-citationStructural mechanism for statin inhibition of HMG-CoA reductase
Istvan, E. S., & Deisenhofer, J. (2001) · Science · doi:10.1126/science.1059344 · Cited by 1,644
Alberts, A. W., Chen, J., Kuron, G., Hunt, V, Huff, J., Hoffman, C., Rothrock, J., Lopez, M., Joshua, H., Harris, E., et al. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3957 · Cited by 1,628
Kureishi, Y., Luo, Z., Shiojima, I., Bialik, A., Fulton, D., Lefer, D. J., Sessa, W. C., & Walsh, K. (2000) · Nature Medicine · doi:10.1038/79510 · Cited by 1,439
Statins as a newly recognized type of immunomodulator.
Kwak, B., Mulhaupt, F., Myit, S., & Mach, F. (2000) · Nature Medicine · doi:10.1038/82219 · Cited by 1,383
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
Kastelein, J. J. P., Akdim, F., Stroes, E. S. G., Zwinderman, A. H., Bots, M. L., Stalenhoef, A. F. H., Visseren, F. L. J., Sijbrands, E. J. G., Trip, M. D., Stein, E. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800742 · Cited by 1,241
Dimmeler, S., Aicher, A., Vasa, M., Mildner-Rihm, C., Adler, K., Tiemann, M., Rütten, H., Fichtlscherer, S., Martin, H., & Zeiher, A. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13152 · Cited by 1,211
Weitz-Schmidt, G., Welzenbach, K., Brinkmann, V., Kamata, T., Kallen, J., Bruns, C., Cottens, S., Takada, Y., & Hommel, U. (2001) · Nature Medicine · doi:10.1038/89058 · Cited by 1,041
Post-transcriptional Regulation of Endothelial Nitric Oxide Synthase mRNA Stability by Rho GTPase
Laufs, U., & Liao, J. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.24266 · Cited by 1,035
Self-citationVasa, M., Fichtlscherer, S., Adler, K., Aicher, A., Martin, H., Zeiher, A. M., & Dimmeler, S. (2001) · Circulation · doi:10.1161/hc2401.092816 · Cited by 1,018
Ridker, P. M., Danielson, E., Fonseca, F. A., Genest, J., Gotto, A. M., Kastelein, J. J., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60447-5 · Cited by 1,010
Endres, M., Laufs, U., Huang, Z., Nakamura, T., Huang, P., Moskowitz, M. A., & Liao, J. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8880 · Cited by 966
Self-citationAnti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms
Jain, M. K., & Ridker, P. M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1901 · Cited by 915
(1995) · The Lancet · doi:10.1016/s0140-6736(95)92836-7 · Cited by 856
New insights into the pharmacodynamic and pharmacokinetic properties of statins
Corsini, A., Bellosta, S., Baetta, R., Fumagalli, R., Paoletti, R., & Bernini, F. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00045-5 · Cited by 796
Hernández-Perera, O., Pérez-Sala, D., Navarro-Antolín, J., Sánchez-Pascuala, R., Hernández, G., Díaz, C., & Lamas, S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1500 · Cited by 763
A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism
Glynn, R. J., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900241 · Cited by 752
Huang, Z., Huang, P. L., Ma, J., Meng, W., Ayata, C., Fishman, M. C., & Moskowitz, M. A. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199609000-00023 · Cited by 718
HMG-CoA reductase inhibitor mobilizes bone marrow–derived endothelial progenitor cells
Llevadot, J., Murasawa, S., Kureishi, Y., Uchida, S., Masuda, H., Kawamoto, A., Walsh, K., Isner, J. M., & Asahara, T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13131 · Cited by 709
Inhibition of Intestinal Cholesterol Absorption by Ezetimibe in Humans
Sudhop, T., Lütjohann, D., Kodal, A., Igel, M., Tribble, D. L., Shah, S., Perevozskaya, I., & von Bergmann, K. (2002) · Circulation · doi:10.1161/01.cir.0000034044.95911.dc · Cited by 682
Statins Have Biphasic Effects on Angiogenesis
Weis, M., Heeschen, C., Glassford, A. J., & Cooke, J. P. (2002) · Circulation · doi:10.1161/hc0602.103393 · Cited by 680
Reciprocal Regulation of Endothelial Nitric-oxide Synthase by Ca2+-Calmodulin and Caveolin
Michel, J. B., Feron, O., Sacks, D., & Michel, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.25.15583 · Cited by 613
Pleiotropic effects of statin therapy: molecular mechanisms and clinical results
Wang, C.-Y., Liu, P.-Y., & Liao, J. K. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.11.004 · Cited by 593
Self-citationAikawa, M., Rabkin, E., Sugiyama, S., Voglic, S. J., Fukumoto, Y., Furukawa, Y., Shiomi, M., Schoen, F. J., & Libby, P. (2001) · Circulation · doi:10.1161/01.cir.103.2.276 · Cited by 588
The evolving role of statins in the management of atherosclerosis
Vaughan, C. J., Gotto, A. M., & Basson, C. T. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00525-2 · Cited by 574
Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy
Takemoto, M., Node, K., Nakagami, H., Liao, Y., Grimm, M., Takemoto, Y., Kitakaze, M., & Liao, J. K. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13350 · Cited by 491
Self-citationRho-Kinase Mediates Hypoxia-Induced Downregulation of Endothelial Nitric Oxide Synthase
Takemoto, M., Sun, J., Hiroki, J., Shimokawa, H., & Liao, J. K. (2002) · Circulation · doi:10.1161/01.cir.0000020682.73694.ab · Cited by 475
Self-citationLandmesser, U., Bahlmann, F., Mueller, M., Spiekermann, S., Kirchhoff, N., Schulz, S., Manes, C., Fischer, D., de Groot, K., Fliser, D., et al. (2005) · Circulation · doi:10.1161/01.cir.0000164260.82417.3f · Cited by 425
Maack, C., Kartes, T., Kilter, H., Schäfers, H.-J., Nickenig, G., Böhm, M., & Laufs, U. (2003) · Circulation · doi:10.1161/01.cir.0000091084.46500.bb · Cited by 423
Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000100688.17280.e6 · Cited by 421
Feron, O., Dessy, C., Desager, J.-P., & Balligand, J.-L. (2001) · Circulation · doi:10.1161/01.cir.103.1.113 · Cited by 417
Pleiotropic Effects of Statins: Benefit Beyond Cholesterol Reduction?
Robinson, J. G., Smith, B., Maheshwari, N., & Schrott, H. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.085 · Cited by 407
Laufs, U., Gertz, K., Huang, P., Nickenig, G., Böhm, M., Dirnagl, U., & Endres, M. (2000) · Stroke · doi:10.1161/01.str.31.10.2442 · Cited by 390
The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study
Tang, T. Y., Howarth, S. P. S., Miller, S. R., Graves, M. J., Patterson, A. J., U-King-Im, J.-M., Li, Z. Y., Walsh, S. R., Brown, A. P., Kirkpatrick, P. J., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.018 · Cited by 389
Laufs, U., Fata, V. L., & Liao, J. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31725 · Cited by 387
Self-citationLaufs, U., Marra, D., Node, K., & Liao, J. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21926 · Cited by 380
Self-citationInhibition of Rho Kinase (ROCK) Leads to Increased Cerebral Blood Flow and Stroke Protection
Rikitake, Y., Kim, H.-H., Huang, Z., Seto, M., Yano, K., Asano, T., Moskowitz, M. A., & Liao, J. K. (2005) · Stroke · doi:10.1161/01.str.0000181077.84981.11 · Cited by 375
Self-citationDiscovery, biochemistry and biology of lovastatin
Alberts, A. W. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90002-1 · Cited by 358
Kruppel-Like Factor 2 as a Novel Mediator of Statin Effects in Endothelial Cells
Sen-Banerjee, S., Mir, S., Lin, Z., Hamik, A., Atkins, G. B., Das, H., Banerjee, P., Kumar, A., & Jain, M. K. (2005) · Circulation · doi:10.1161/circulationaha.104.525774 · Cited by 354
Wassmann, S., Laufs, U., Bäumer, A. T., Müller, K., Konkol, C., Sauer, H., Böhm, M., & Nickenig, G. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12257-2 · Cited by 345
Wolfrum, S., Dendorfer, A., Rikitake, Y., Stalker, T. J., Gong, Y., Scalia, R., Dominiak, P., & Liao, J. K. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000142813.33538.82 · Cited by 328
Self-citationSimvastatin Preserves the Ischemic-Reperfused Myocardium in Normocholesterolemic Rat Hearts
Lefer, A. M., Campbell, B., Shin, Y.-K., Scalia, R., Hayward, R., & Lefer, D. J. (1999) · Circulation · doi:10.1161/01.cir.100.2.178 · Cited by 326
The Rac and Rho Hall of Fame: A Decade of Hypertrophic Signaling Hits
Brown, J. H., Del Re, D. P., & Sussman, M. A. (2006) · Circulation Research · doi:10.1161/01.res.0000216039.75913.9e · Cited by 323
Michel, J. B., Feron, O., Sase, K., Prabhakar, P., & Michel, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25907 · Cited by 320
Cell cycle-specific effects of lovastatin.
Jakóbisiak, M., Bruno, S., Skierski, J. S., & Darzynkiewicz, Z. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3628 · Cited by 295
Statins and Cardiovascular Diseases: From Cholesterol Lowering to Pleiotropy
Zhou, Q., & Liao, J. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787315684 · Cited by 294
Self-citationBloomfield Rubins, H., Davenport, J., Babikian, V., Brass, L. M., Collins, D., Wexler, L., Wagner, S., Papademetriou, V., Rutan, G., & Robins, S. J. (2001) · Circulation · doi:10.1161/01.cir.103.23.2828 · Cited by 269
Notarbartolo, A., Davı̀, G., Averna, M., Barbagallo, C. M., Ganci, A., Giammarresi, C., Placa, F. P. L., & Patrono, C. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.2.247 · Cited by 259
Nishimura, T., Vaszar, L. T., Faul, J. L., Zhao, G., Berry, G. J., Shi, L., Qiu, D., Benson, G., Pearl, R. G., & Kao, P. N. (2003) · Circulation · doi:10.1161/01.cir.0000087592.47401.37 · Cited by 251
Yano, M., Matsumura, T., Senokuchi, T., Ishii, N., Murata, Y., Taketa, K., Motoshima, H., Taguchi, T., Sonoda, K., Kukidome, D., et al. (2007) · Circulation Research · doi:10.1161/01.res.0000268411.49545.9c · Cited by 235
Liu, P.-Y., Liu, Y.-W., Lin, L.-J., Chen, J.-H., & Liao, J. K. (2009) · Circulation · doi:10.1161/circulationaha.108.813311 · Cited by 226
Self-citationG Proteins and Small GTPases: Distant Relatives Keep in Touch
Hall, A. (1998) · Science · doi:10.1126/science.280.5372.2074 · Cited by 217
Takayama, T., Hiro, T., Yamagishi, M., Daida, H., Hirayama, A., Saito, S., Yamaguchi, T., Matsuzaki, M., & The COSMOS Investigators (2009) · Circulation Journal · doi:10.1253/circj.cj-09-0358 · Cited by 211
Scalia, R., Gooszen, M. E., Jones, S. P., Hoffmeyer, M., Rimmer, D. M., Trocha, S. D., Huang, P. L., Smith, M. B., Lefer, A. M., & Lefer, D. J. (2001) · Circulation · doi:10.1161/01.cir.103.21.2598 · Cited by 204
Stalker, T. J., Lefer, A. M., & Scalia, R. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704070 · Cited by 202
Impact of HMG CoA reductase inhibition on small GTPases in the heart
Laufs, U. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00540-5 · Cited by 202
Chandrasekar, B., Mummidi, S., Mahimainathan, L., Patel, D. N., Bailey, S. R., Imam, S. Z., Greene, W. C., & Valente, A. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600200200 · Cited by 193
Veillard, N. R., Braunersreuther, V., Arnaud, C., Burger, F., Pelli, G., Steffens, S., & Mach, F. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.015 · Cited by 175
Germershausen, J. I., Hunt, V. M., Bostedor, R. G., Bailey, P. J., Karkas, J. D., & Alberts, A. W. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92773-3 · Cited by 170
Tanne, D., Koren-Morag, N., Graff, E., & Goldbourt, U. (2001) · Circulation · doi:10.1161/hc4901.100384 · Cited by 158
Zelvyté, I., Dominaitiene, R., Crisby, M., & Janciauskiene, S. M. (2002) · Pharmacological Research · doi:10.1006/phrs.2001.0922 · Cited by 152
Rezaie-Majd, A., Prager, G. W., Bucek, R. A., Schernthaner, G.-H., Maca, T., Kress, H. G., Valent, P., Binder, B. R., Minar, E., & Baghestanian, M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000059384.34874.f0 · Cited by 146
Antiplatelet Actions of Statins and Fibrates Are Mediated by PPARs
Ali, F. Y., Armstrong, P. C. J., Dhanji, A., Tucker, A. T., Paul‐Clark, M. J., Mitchell, J. A., & Warner, T. D. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.183160 · Cited by 143
Fichtlscherer, S., Schmidt‐Lucke, C., Bojunga, S., Rössig, L., Heeschen, C., Dimmeler, S., & Zeiher, A. M. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi881 · Cited by 140
Rasmussen, L. M., Hansen, P. R., NABIPOUR, M. T., Olesen, P., Kristiansen, M. T., & Ledet, T. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3600363 · Cited by 134
Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells
Mulhaupt, F. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00515-7 · Cited by 134
Molecular Imaging of Matrix Metalloproteinase in Atherosclerotic Lesions
Fujimoto, S., Hartung, D., Ohshima, S., Edwards, D. S., Zhou, J., Yalamanchili, P., Azure, M., Fujimoto, A., Isobe, S., Matsumoto, Y., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.048 · Cited by 133
Simvastatin Attenuates Oxidant-Induced Mitochondrial Dysfunction in Cardiac Myocytes
Jones, S. P., Teshima, Y., Akao, M., & Marbán, E. (2003) · Circulation Research · doi:10.1161/01.res.0000097262.21507.df · Cited by 124
Shao, H., Tan, Y., Eton, D., Yang, Z., Uberti, M. G., Li, S., Schulick, A. H., & Yu, H. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0785 · Cited by 117
Napoli, P. D., Taccardi, A. A., Grilli, A., Delutiis, M. A., Barsotti, A., Felaco, M., & DeCaterina, R. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.02.008 · Cited by 112
Perspectives in Cholesterol-Lowering Therapy
Bruckert, É., Giral, P., & Tellier, P. (2003) · Circulation · doi:10.1161/01.cir.0000072345.98581.24 · Cited by 112
HMG-CoA Reductase Inhibitors Decrease Angiotensin II–Induced Vascular Fibrosis
Rupérez, M., Rodrigues‐Díez, R., Blanco‐Colio, L. M., et al. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.091264 · Cited by 109
Wagner, A. H., Gebauer, M., Güldenzoph, B., & Hecker, M. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000037098.20829.31 · Cited by 109
New Evidence for Beneficial Effects of Statins Unrelated to Lipid Lowering
Palinski, W. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.1.3 · Cited by 108
Yang, Z., Kozai, T., van der Loo, B., Viswambharan, H., Lachat, M. L., Turina, M. I., Maliñski, T., & Lüscher, T. F. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00924-4 · Cited by 104
Corti, R., Osende, J. I., Fallon, J. T., Fuster, V., Mizsei, G., Jneid, H. M., Wright, S. D., Chaplin, W. F., & Badimón, J. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.048 · Cited by 100
Increased Rho Kinase Activity in a Taiwanese Population With Metabolic Syndrome
Liu, P., Chen, J.-H., Lin, L.-J., & Liao, J. K. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.12.043 · Cited by 99
Self-citationShimizu, K., Aikawa, M., Takayama, K., Libby, P., & Mitchell, R. N. (2003) · Circulation · doi:10.1161/01.cir.0000092949.67153.74 · Cited by 99
Wong, J., Quinn, C. M., Gelissen, I. C., Jessup, W., & Brown, A. J. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.030 · Cited by 98
Shiraya, S., Miyake, T., Aoki, M., Fujiwara, Y., Ohgi, S., Nishimura, M., Ogihara, T., & Morishita, R. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.03.020 · Cited by 97
Undas, A., Celińska‐Löwenhoff, M., Domagała, T. B., Iwaniec, T., Dropiński, J., Löwenhoff, T., & Szczeklik, A. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-01-0067 · Cited by 90
Statin Therapy for Stroke Prevention
Nassief, A. M., & Marsh, J. D. (2008) · Stroke · doi:10.1161/strokeaha.107.501361 · Cited by 86
Rashid, M., Tawara, S., Fukumoto, Y., Seto, M., Yano, K., & Shimokawa, H. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-0817 · Cited by 86
Chen, Z., Fukutomi, T., Zago, A. C., Ehlers, R., Detmers, P. A., Wright, S. D., Rogers, C., & Simon, D. I. (2002) · Circulation · doi:10.1161/01.cir.0000022843.76104.01 · Cited by 85
Ostad, M. A., Eggeling, S., Tschentscher, P., Schwedhelm, E., Böger, R. H., Wenzel, P., Meinertz, T., Münzel, T. F., & Warnholtz, A. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.11.032 · Cited by 77
Xu, J., Liu, X., Chen, J., Zacharek, A., Cui, X., Savant‐Bhonsale, S., Liu, Z., & Chopp, M. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00310.2008 · Cited by 75
Hauck, L., Harms, C., Grothe, D., An, J., Gertz, K. R., Kronenberg, G., Dietz, R., Endres, M., & von Harsdorf, R. (2006) · Circulation Research · doi:10.1161/01.res.0000254704.92532.b9 · Cited by 75
Haramaki, N., Ikeda, H., Takenaka, K., Katoh, A., Sugano, R., Yamagishi, S., Matsuoka, H., & Imaizumi, T. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.106.128793 · Cited by 68
Improved Lymphocyte Function-associated Antigen-1 (LFA-1) Inhibition by Statin Derivatives
Weitz‐Schmidt, G., Welzenbach, K., Dawson, J., & Kallen, J. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407951200 · Cited by 67
Mukai, Y., Wang, C.-Y., Rikitake, Y., & Liao, J. K. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00868.2006 · Cited by 63
Self-citationRosuvastatin Reduces Platelet Activation in Heart Failure
Schäfer, A., Fraccarollo, D., Eigenthaler, M., Tas, P. W. L., Firnschild, A., Frantz, S., Ertl, G., & Bauersachs, J. K. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000161926.43967.df · Cited by 61
A Method for Measuring Rho Kinase Activity in Tissues and Cells
Liu, P., & Liao, J. K. (2008) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)00414-4 · Cited by 60
Self-citationLi, M., Liu, Y., Dutt, P., Fanburg, B. L., & Toksoz, D. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00133.2007 · Cited by 60
HMG-CoA reductase inhibitors induce apoptosis in neointima-derived vascular smooth muscle cells
Erl, W., Hristov, M., Neureuter, M., Yan, Z.-Q., Hansson, G. K., & Weber, P. C. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00201-6 · Cited by 57
Essential Role of TGF-β/Smad Pathway on Statin Dependent Vascular Smooth Muscle Cell Regulation
Rodríguez‐Vita, J., Sánchez-Galán, E., Santamaría, B., Sánchez‐López, E., Rodrigues‐Díez, R., Blanco‐Colio, L. M., Egido, J., Ortíz, A., & Ruiz‐Ortega, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003959 · Cited by 55
Kimura, T., Mogi, C., Tomura, H., Kuwabara, A., Im, D., Sato, K., Kurose, H., Murakami, M., & Okajima, F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7332 · Cited by 53
Tanimoto, A., Murata, Y., Wang, K., Tsutsui, M., Kohno, K., & Sasaguri, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m708853200 · Cited by 53
Opper, C., Clement, C., Schwarz, H., Krappe, J., Steinmetz, A., Schneider, J. E., & Wesemann, W. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05448-r · Cited by 53
Illingworth, D. R., & Tobert, J. A. (2001) · Advances in protein chemistry · doi:10.1016/s0065-3233(01)56003-9 · Cited by 53
Desjardins, F., Sekkali, B., Verreth, W., Pelat, M., Keyzer, D. D., Mertens, A. C., Smith, G., Herregods, M., Holvoet, P., & Balligand, J. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm540 · Cited by 51
Pravastatin reduces thrombogenicity by mechanisms beyond plasma cholesterol lowering
Casaní, L., Sánchez-Gómez, S., Vilahur, G., & Badimón, L. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-04-0245 · Cited by 50
Kunieda, Y., Nakagawa, K., Nishimura, H., Kato, H., Ukimura, N., Yano, S., Kawano, H., Kimura, S., Nakagawa, M., & Tsuji, H. (2003) · Thrombosis Research · doi:10.1016/s0049-3848(03)00346-3 · Cited by 48
Differential Modulation of Caveolin-1 Expression in Cells of the Vasculature by Statins
Plenz, G. A. M., Hofnagel, O., & Robenek, H. (2004) · Circulation · doi:10.1161/01.cir.0000111128.83347.7a · Cited by 47
Bulhak, A., Roy, J., Hedin, U., Sjöquist, P.-O. B., & Pernow, J. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01354.2006 · Cited by 45
Suzuki, G., Iyer, V., Cimato, T. R., & Canty, J. M. (2008) · Circulation Research · doi:10.1161/circresaha.108.188730 · Cited by 42
Monitoring the Cellular Effects of HMG-CoA Reductase Inhibitors In Vitro and Ex Vivo
Cicha, I., Schneiderhan‐Marra, N., Yılmaz, A., Garlichs, C. D., & Goppelt‐Struebe, M. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000145943.19099.a3 · Cited by 38
Friedrich, E. B., Clever, Y. P., Waßmann, S., Werner, N., Böhm, M., & Nickenig, G. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.217 · Cited by 36
Sundararaj, K. P., Samuvel, D. J., Li, Y., Nareika, A., Slate, E. H., Sanders, J. J., Lopes-Virella, M. F., & Huang, Y. Q. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0108064 · Cited by 35
Undas, A., Brummel‐Ziedins, K. E., Potaczek, D. P., Stobierska-Dzierżek, B., Bryniarski, L., Szczeklik, A., & Mann, K. G. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02165.x · Cited by 34
Matsuki, A., Igawa, A., Nozawa, T., Nakadate, T., Igarashi, N., Nonomura, M., & Inoue, H. (2006) · Circulation Journal · doi:10.1253/circj.70.1643 · Cited by 29
Squizzato, A., Romualdi, E., & Ageno, W. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02030.x · Cited by 29
D’Annunzio, V., Donato, M., Erni, L., Miksztowicz, V., Buchholz, B., Carrión, C. L., Schreier, L. E., Wikinski, R., Gelpi, R. J., Berg, G. A., et al. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318197c5e9 · Cited by 27
Regulation of macrophage apoE secretion and sterol efflux by the LDL receptor
Lucic, D. X., Huang, Z., Gu, D., Altenburg, M. K., Maeda, N., & Mazzone, T. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600259-jlr200 · Cited by 27
Djaldetti, M., Salman, H., Bergman, M., & Bessler, H. (2005) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2005.09.009 · Cited by 25
Fujino, M., Miura, S.-I., Matsuo, Y., Tanigawa, H., Kawamura, A., & Saku, K. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.008 · Cited by 19
Ohkita, M., Sugii, M., Ka, Y., Kitamura, A., Mori, T., Hayashi, T., Takaoka, M., & Matsumura, Y. (2006) · PubMed · Cited by 17
Cited by
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162
Interpretation of the evidence for the efficacy and safety of statin therapy
Collins, R., Reith, C., Emberson, J., Armitage, J., Baigent, C., Blackwell, L., Blumenthal, R., Danesh, J., Smith, G. D., DeMets, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31357-5 · Cited by 1,857
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.018 · Cited by 1,582
ESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.028 · Cited by 706
Molecular Biology of Atherosclerosis
Hopkins, P. N. (2013) · Physiological Reviews · doi:10.1152/physrev.00004.2012 · Cited by 459
Metadata
- Authors
- Zhou, Q., & Liao, J. K.
- Venue
- Circulation Journal
- Publisher
- Japanese Circulation Society
- Published
- 2010
- Volume
- 74
- Issue
- 5
- Pages
- 818-826
- ISSN
- 1346-9843 (ISSN-L)
- 1347-4820
- OpenAlex
- W127809968
- Cited by
- 567
- References
- 127
- FWCI
- 59.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.